Literature DB >> 32650001

The common microRNA signatures associated with mitochondrial dysfunction in different muscular dystrophies.

Evrim Aksu-Menges1, Yeliz Zulfiye Akkaya-Ulum1, Didem Dayangac-Erden1, Banu Balci-Peynircioglu1, Ayse Yuzbasioglu1, Haluk Topaloglu2, Beril Talim3, Burcu Balci-Hayta4.   

Abstract

Secondary mitochondrial damage in skeletal muscles is a common feature of different neuromuscular disorders (NMD), which fall outside the mitochondrial cytopathies. The common cause of mitochondrial dysfunction and structural changes in skeletal muscle tissue remains to be discovered. Although they are associated with different clinical, genetic, and pathological backgrounds, the pathomechanisms underlying NMDs might be attributed to the complex interaction and crosstalk between mitochondria and the associated microRNAs (miRNAs). In this study, we aimed to identify the common miRNA signatures that are associated with mitochondrial damage in different muscular dystrophies (MDs) [Duchenne Muscular Dystrophy (DMD), Megaconial Congenital Muscular Dystrophy (CMD), Ullrich CMD (UCMD), and alpha-dystroglycanopathy (αDGpathy)]. We analyzed the miRnome profiles of skeletal muscle biopsies acquired from four different MD groups and control individuals by miRNA microarray. We identified 17 common upregulated miRNAs in all the tested MD groups. A specific bioinformatics approach identified 10 of these miRNAs to be specifically related to the mitochondrial pathways. Six miRNAs, miR-134-5p, miR-199a-5p, miR-382-5p, miR-409-3p, miR-497-5p, and miR-708-5p, were associated with the top four mitochondrial pathways and were thus selected as priority candidates for further validation by quantitative Real-Time PCR analysis. We demonstrate, for the first time, common upregulated miRNAs that are associated with mitochondrial damage in different MD groups, therefore, contributing to the pathophysiology. Our findings may open a new gate towards therapeutics.
Copyright © 2020. Published by Elsevier Inc.

Entities:  

Keywords:  microRNA; microarray analysis; mitochondrial damage; muscular dystrophy

Year:  2020        PMID: 32650001     DOI: 10.1016/j.ajpath.2020.06.011

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  6 in total

1.  MiR-382 Functions on the Regulation of Melanogenesis via Targeting dct in Rainbow Trout (Oncorhynchus mykiss).

Authors:  Shenji Wu; Jinqiang Huang; Yongjuan Li; Zhe Liu; Lu Zhao
Journal:  Mar Biotechnol (NY)       Date:  2022-07-27       Impact factor: 3.727

2.  Non-Coding RNAs in the Transcriptional Network That Differentiates Skeletal Muscles of Sedentary from Long-Term Endurance- and Resistance-Trained Elderly.

Authors:  Paola De Sanctis; Giuseppe Filardo; Provvidenza Maria Abruzzo; Annalisa Astolfi; Alessandra Bolotta; Valentina Indio; Alessandro Di Martino; Christian Hofer; Helmut Kern; Stefan Löfler; Maurilio Marcacci; Marina Marini; Sandra Zampieri; Cinzia Zucchini
Journal:  Int J Mol Sci       Date:  2021-02-03       Impact factor: 5.923

3.  Secretory products from epicardial adipose tissue induce adverse myocardial remodeling after myocardial infarction by promoting reactive oxygen species accumulation.

Authors:  Shuang Hao; Xin Sui; Jing Wang; Jingchao Zhang; Yu Pei; Longhui Guo; Zhenxing Liang
Journal:  Cell Death Dis       Date:  2021-09-13       Impact factor: 8.469

Review 4.  Dystroglycanopathy: From Elucidation of Molecular and Pathological Mechanisms to Development of Treatment Methods.

Authors:  Motoi Kanagawa
Journal:  Int J Mol Sci       Date:  2021-12-06       Impact factor: 5.923

5.  miRNome profiling in Duchenne muscular dystrophy; identification of asymptomatic and manifesting female carriers.

Authors:  Nahla O Mousa; Ahmed A Sayed; Nagia Fahmy; Mariam G Elzayat; Usama Bakry; Ahmed Abdellatif; Waheed K Zahra; Ahmed Osman
Journal:  Biosci Rep       Date:  2021-09-30       Impact factor: 3.840

6.  Serum microRNAs in osteoporotic fracture and osteoarthritis: a genetic and functional study.

Authors:  Clara Pertusa; Juan J Tarín; Antonio Cano; Miguel Ángel García-Pérez; Damián Mifsut
Journal:  Sci Rep       Date:  2021-09-29       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.